Recent News

• 08.06.2026 - BD Reports Third Quarter Fiscal 2026 Financial Results
• 07.29.2026 - EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch
• 07.28.2026 - BD Board Declares Dividend
• 07.22.2026 - Mike Garrison to Retire from BD
• 07.09.2026 - BD to Announce Financial Results for its Third Quarter of Fiscal 2026
• 06.23.2026 - BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System
• 06.23.2026 - BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System
• 05.21.2026 - BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System
• 05.21.2026 - BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System
• 05.18.2026 - Peter Menziuso Named EVP and President, BD Interventional

Recent Filings

• 08.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.06.2026 - 8-K Current report
• 08.06.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.03.2026 - 144 Report of proposed sale of securities
• 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.27.2026 - 144 Report of proposed sale of securities
• 07.22.2026 - 8-K Current report
• 07.22.2026 - EX-99.1 EX-99.1